Xin Lang Zheng Quan·2025-07-30 02:56Core Viewpoint - The recent personnel changes at Xishan Technology reflect the company's ongoing transformation and the challenges it faces in maintaining growth amid declining profits and market pressures [1][4][12]. Group 1: Personnel Changes - The Vice President Bian Benben has submitted his resignation to focus on his role as the National Sales Director, effective July 28, 2025 [3][4]. - Bian, who joined the company in 2006, saw his annual salary drop from 1.08 million yuan in 2023 to 634,100 yuan in 2024, indicating significant performance pressures [3][4]. Group 2: Financial Performance - Xishan Technology's net profit fell by 15.92% in 2024, with a staggering 55.66% decline in the first quarter of 2025 [4][12]. - The company's stock price has plummeted nearly 70% from its peak of 135.8 yuan per share in June 2023 to 69.70 yuan as of July 29, 2024, despite a 14% increase in 2025 [5][12]. Group 3: Shareholder Actions - To restore market confidence, the controlling shareholder, Xishan Investment, plans to buy back shares worth between 5 million and 10 million yuan within six months [5][6]. - Xishan Investment and its concerted parties hold a total of 23.75 million shares, representing 52.20% of the company [6][7]. Group 4: Strategic Shifts - Xishan Technology is transitioning from traditional surgical power devices to becoming a comprehensive provider of minimally invasive surgical tools, with a focus on breaking foreign monopolies [9][11]. - The company is expanding into the endoscope market, moving from rigid to flexible endoscopes, which could open new growth avenues as domestic production rates increase [10][11]. Group 5: Future Outlook - The personnel changes and strategic shifts signify a critical phase for Xishan Technology, as it seeks to regain control and drive innovation in the face of declining traditional revenue streams [12].